Studies in yeast, flies and mice have shown that relatively low doses of rapamycin often increase the creatures’ lifespans.
A new study reveals rapamycin may undermine exercise benefits, challenging its hype as a longevity breakthrough.
Hosted on MSN
Fighting cancer cachexia with nutrition and care
Cancer cachexia robs patients of weight, muscle, and strength, undermining treatment success and quality of life. Experts now advocate for a multimodal approach—combining nutrition, exercise, and ...
A large-scale, 5-year clinical trial from the Generation 100 study in Norway has found that high-intensity interval training ...
Kerstin Haase is in the Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK. Mariam Jamal-Hanjani is in the Cancer Research UK Lung ...
Clinical Trials Arena on MSN
CatalYm doses first patient in Phase II/III VINCIT trial
The trial plans to enrol approximately 518 participants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results